Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision v3.4.3 to the study record history. Removed Revision v3.4.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history and the previous revision (v3.4.1) was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry (v3.4.1) was added to the study record history, replacing the prior v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now includes UI explanations for how changes are highlighted (green additions, red deletions) and a glossary toggle, and the revision label was updated from v3.3.4 to v3.4.0.SummaryDifference1%

- Check61 days agoChange DetectedThe page history now shows a new revision entry v3.3.4 and removes v3.3.3, which is a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry Revision: v3.3.3 has been added to the record history. The items HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed from the record history.SummaryDifference0.2%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.